SPG20 antibody (N-Term)
Quick Overview for SPG20 antibody (N-Term) (ABIN2365481)
Target
See all SPG20 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- SPG20, NT (Spastic Paraplegia 20 Protein, Trans-activated By Hepatitis C Virus Core Protein 1, Spartin, TAHCCP1, KIAA0610)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogen
- Synthetic peptide selected from the N-terminal region of human SPG20 (KLH).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
Alternative Name
- SPG20
-
NCBI Accession
- NP_055902
-
UniProt
- Q8N0X7
-
Pathways
- Regulation of Cell Size, SARS-CoV-2 Protein Interactome
Target
-